BHVN Relative Valuation
BHVN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BHVN is overvalued; if below, it's undervalued.
Historical Valuation
Biohaven Ltd (BHVN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 248.89 is considered Undervalued compared with the five-year average of -4.61. The fair price of Biohaven Ltd (BHVN) is between 27.58 to 32.99 according to relative valuation methord. Compared to the current price of 13.49 USD , Biohaven Ltd is Undervalued By 51.09%.
Relative Value
Fair Zone
27.58-32.99
Current Price：13.49
51.09%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
5.22
P/B
Median3y
7.52
Median5y
7.52
-44.79
FCF Yield
Median3y
-19.49
Median5y
-19.49
Competitors Valuation Multiple
The average P/S ratio for BHVN's competitors is 1381.00, providing a benchmark for relative valuation. Biohaven Ltd Corp (BHVN) exhibits a P/S ratio of 253.54, which is -81.64% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Biohaven Ltd (BHVN) currently overvalued or undervalued?
What is Biohaven Ltd (BHVN) fair value?
How does BHVN's valuation metrics compare to the industry average?
What is the current P/B ratio for Biohaven Ltd (BHVN) as of Jul 17 2025?
What is the current FCF Yield for Biohaven Ltd (BHVN) as of Jul 17 2025?
What is the current Forward P/E ratio for Biohaven Ltd (BHVN) as of Jul 17 2025?